Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
It requires careful administration and may be recommended by healthcare providers for those seeking more direct or intensive benefits
Azizzadeh, who advises these skin types to try the retinoin-sandwich technique: two thin layers of moisturizer as the bread, filled with tretinoin
All chronic diseases, including COVID-19 with the long-COVID-19-syndrome (271), are characterized by the presence of persistent chronic inflammation and sustained generation of reactive oxygen and nitrogen species that when confronted with inadequate antioxidant defenses (likely leading components of anti-inflammaging) precipitate excessive oxidative stress
Fatigue and Lethargy: Users may experience unexpected fatigue, impacting daily functioning
Grab a fold of skin at your injection site between your thumb and index finger